# First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-lorlatinib-or-crizotinib-in-advanced-i-alk-i-positive-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alice T. Shaw,Todd M. Bauer,Filippo de Marinis,Enriqueta Felip,Yasushi Goto,Geoffrey Liu,Julien Mazières,Dong‐Wan Kim,Tony Mok,Anna Polli,Holger Thurm,Anna Maria Calella,Gerson Peltz,Benjamin Solomon |
| Citations | 1,092 |
| DOI | 10.1056/nejmoa2027187 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa2027187?articleTools=true |
| OpenAlex ID | https://openalex.org/W3101089668 |
| PMID | 33207094 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)
- [Julien Mazières](https://scholariq.org/researchers/julien-mazieres/)
- [Dong‐Wan Kim](https://scholariq.org/researchers/dong-wan-kim/)
- [Enriqueta Felip](https://scholariq.org/researchers/enriqueta-felip/)
- [Benjamin Solomon](https://scholariq.org/researchers/benjamin-solomon/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.